Skip to main content
Top
Published in: Annals of Hematology 10/2009

01-10-2009 | Letter to the Editor

Telomere length of donors influences granulocyte recovery in children after hematopoietic stem cell transplantation

Authors: Rosa Mangerini, Edoardo Lanino, Paola Terranova, Maura Faraci, Maria Pia Pistillo, Gian Franco Gaetani, Anna Maria Ferraris

Published in: Annals of Hematology | Issue 10/2009

Login to get access

Excerpt

Dear Editor, …
Literature
2.
go back to reference Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA (1997) Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 90:182–193PubMed Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA (1997) Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 90:182–193PubMed
5.
8.
go back to reference Lincz LF, Scorgie FE, Sakoff JA, Fagan KA, Ackland SP, Enno A (2004) Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 34:439–445, doi:10.1038/sj.bmt.1704607 PubMedCrossRef Lincz LF, Scorgie FE, Sakoff JA, Fagan KA, Ackland SP, Enno A (2004) Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 34:439–445, doi:10.​1038/​sj.​bmt.​1704607 PubMedCrossRef
9.
go back to reference Vaziri H, Schächter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D, Harley CB (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52:661–667PubMed Vaziri H, Schächter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D, Harley CB (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52:661–667PubMed
11.
go back to reference Rufer N, Brümmendorf TH, Chapuis B, Helg C, Lansdorp PM, Roosnek E (2001) Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood 97:575–577, doi:10.1182/blood.V97.2.575 PubMedCrossRef Rufer N, Brümmendorf TH, Chapuis B, Helg C, Lansdorp PM, Roosnek E (2001) Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood 97:575–577, doi:10.​1182/​blood.​V97.​2.​575 PubMedCrossRef
12.
go back to reference Roelofs H, de Pauw ES, Zwinderman AH, Opdam SM, Willemze R, Tanke HJ, Fibbe WE (2003) Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation. Blood 101:358–362, doi:10.1182/blood-2002-06-1832 PubMedCrossRef Roelofs H, de Pauw ES, Zwinderman AH, Opdam SM, Willemze R, Tanke HJ, Fibbe WE (2003) Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation. Blood 101:358–362, doi:10.​1182/​blood-2002-06-1832 PubMedCrossRef
Metadata
Title
Telomere length of donors influences granulocyte recovery in children after hematopoietic stem cell transplantation
Authors
Rosa Mangerini
Edoardo Lanino
Paola Terranova
Maura Faraci
Maria Pia Pistillo
Gian Franco Gaetani
Anna Maria Ferraris
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 10/2009
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-009-0712-z

Other articles of this Issue 10/2009

Annals of Hematology 10/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine